Batatasin IV is primarily studied for its biological activities, particularly in the field of pharmacology and natural product research. It exhibits antioxidant properties, helping to neutralize free radicals and reduce oxidative stress in cellular systems. This makes it a compound of interest in developing therapies for neurodegenerative diseases and age-related disorders.

It also demonstrates anti-inflammatory effects by modulating key inflammatory pathways, suggesting potential use in treating chronic inflammatory conditions. Research has indicated antimicrobial activity, showing effectiveness against certain bacteria and fungi, which could lead to applications in antimicrobial agent development.

Additionally, Batatasin IV has been investigated for its antidiabetic potential due to its ability to influence glucose metabolism and improve insulin sensitivity in preclinical models. Its cytotoxic properties against certain cancer cell lines highlight its role in oncology research, particularly in identifying new lead compounds for anticancer drug development.

Due to its natural origin and multi-target activities, Batatasin IV serves as a valuable scaffold for designing derivatives with enhanced efficacy and selectivity for therapeutic applications.